missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Melanoma Discriminated Antigen Monoclonal Antibody (PAL-M1)
Descripción
Antibody PAL-M1 stains the majority of primary melanomas and the large majority of metastases and is directed against the transferrin receptor (CD71). Local staining of dysplastic nevocellular nevi may be observed. Common nevocellular nevi rarely stain.
Melanoma is a malignant tumor of melanocytes which are found predominantly in skin but also in the bowel and the eye (see uveal melanoma). It is one of the rarer types of skin cancer but causes the majority of skin cancer related deaths. Despite many years of intensive laboratory and clinical research, the sole effective cure is surgical resection of the primary tumor before it achieves a thickness of greater than 1 mm.
Especificaciones
Especificaciones
| Antígeno | Melanoma Discriminated Antigen |
| Aplicaciones | Flow Cytometry, Immunohistochemistry (Frozen), Western Blot |
| Clasificación | Monoclonal |
| Clon | PAL-M1 |
| Concentración | Conc. Not Determined |
| Conjugado | Unconjugated |
| Formulación | tissue culture supernatant with 10mM sodium azide |
| Alias de gen | melanoma antigen; melanoma associated antigen |
| Especie del huésped | Mouse |
| Inmunógeno | Human melanoma metastases tissue. |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?